2019
DOI: 10.18632/aging.102152
|View full text |Cite
|
Sign up to set email alerts
|

Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers

Abstract: Background: Growing studies have reported that pseudogenes play key roles in multiple human cancers. However, expression and roles of pseudogenes in renal cell carcinoma remains absent. Results: 31 upregulated and 16 downregulated pseudogenes were screened. Higher expression of DUXAP8 and DUXAP9 indicated poorer prognosis of kidney cancer. 33 and 5 miRNAs were predicted to potentially binding to DUXAP8 and DUXAP9, respectively. miR-29c-3p was identified as the most potential binding miRNAs of DUXAP8… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 58 publications
1
21
0
Order By: Relevance
“…They also showed that DUXAP10 was positively correlated with poor prognosis and epigenetically silenced p21 by recruiting EZH2 to the promoter of p21, thereby promoting cell proliferation and metastasis. Chen et al (2019) demonstrated that DUXAP8 and DUXAP9 were significantly upregulated in renal cell carcinoma, promoted tumor growth and served as two unfavorable prognostic biomarkers for patients with renal cell carcinoma. DUXAP8 was also discovered to enhance progression of renal cell carcinoma (Huang T. et al, 2018).…”
Section: Endometrial Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…They also showed that DUXAP10 was positively correlated with poor prognosis and epigenetically silenced p21 by recruiting EZH2 to the promoter of p21, thereby promoting cell proliferation and metastasis. Chen et al (2019) demonstrated that DUXAP8 and DUXAP9 were significantly upregulated in renal cell carcinoma, promoted tumor growth and served as two unfavorable prognostic biomarkers for patients with renal cell carcinoma. DUXAP8 was also discovered to enhance progression of renal cell carcinoma (Huang T. et al, 2018).…”
Section: Endometrial Cancermentioning
confidence: 99%
“…To date, two DUXA-associated pseudogene-derived lncRNAs, DUXAP8 and DUXAP9, have been discovered to act as ceRNAs to enhance cancer development. For example, Chen et al (2019) demonstrated that DUXAP8 and DUXAP9 enhanced growth of renal cell carcinoma by binding to miR-29c-3p and leading to upregulation of COL1A1 and COL1A2; Huang T. et al (2018) suggested that DUXAP8 facilitated progression of renal cell carcinoma by sponging miR-126. DUXAP8, upregulated by STAT3, also fueled migration and invasion of colorectal cancer by functioning as a ceRNA for miR-577 to regulate RAB14 (Du et al, 2019).…”
Section: Duxap8 and Duxap9mentioning
confidence: 99%
“…SLC6A1 and COL1A2 are unfavorable prognostic markers in renal cancer. [ 40 , 41 ] SYT1 promotes colon cancer cell proliferation, migration, and invasion. [ 42 ] COL19A1 encodes the alpha chain of type XIX collagen, but the function of this collagen is not well known.…”
Section: Discussionmentioning
confidence: 99%
“…In the meantime, high expression of this gene is related to a poor prognosis. In addition to this study, this lncRNA has been linked to several other cancer types, renal cell carcinoma [ 40 ] and colon cancer [ 33 ], for example. For SCCs specifically, it is linked to esophageal squamous cell carcinoma [ 37 ].…”
Section: Discussionmentioning
confidence: 99%